Cite
Radiomic assessment as a method for predicting tumor mutation burden (TMB) of bladder cancer patients: a feasibility study
MLA
Zhi-gang Yang, et al. “Radiomic Assessment as a Method for Predicting Tumor Mutation Burden (TMB) of Bladder Cancer Patients: A Feasibility Study.” BMC Cancer, vol. 21, no. 1, July 2021, pp. 1–9. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6e7edf99a06f11eadde204c27dd4e5ec&authtype=sso&custid=ns315887.
APA
Zhi-gang Yang, Youling Gong, Wen-lei Qian, Wei-feng Yan, Xin Tang, & Tong Pang. (2021). Radiomic assessment as a method for predicting tumor mutation burden (TMB) of bladder cancer patients: a feasibility study. BMC Cancer, 21(1), 1–9.
Chicago
Zhi-gang Yang, Youling Gong, Wen-lei Qian, Wei-feng Yan, Xin Tang, and Tong Pang. 2021. “Radiomic Assessment as a Method for Predicting Tumor Mutation Burden (TMB) of Bladder Cancer Patients: A Feasibility Study.” BMC Cancer 21 (1): 1–9. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6e7edf99a06f11eadde204c27dd4e5ec&authtype=sso&custid=ns315887.